Added Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Advanced Stage Disease in Patients With Endometrial Carcinoma

Evis Sala, Robin Crawford, Emma Senior, Emma Louise Senior, Ashley Shaw, Bryony Simcock, Kalliopi Vrotsou, C. Palmer, Christopher Palmer, Pauline Rajan, P Rajan, Ilse Joubert, David J. Lomas, David Lomas
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2009 · vol. 19(1) , pp. 141–146 · doi:10.1111/igc.0b013e3181995fd9 · PMID:19258956 · W2055367343
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated whether dynamic contrast-enhanced MRI can predict advanced stage disease in patients with endometrial carcinoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Endometrial Neoplasms Magnetic Resonance Imaging Aged Aged, 80 and over Contrast Media Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Female Humans Magnetic Resonance Imaging Middle Aged Neoplasm Staging Neoplasm Staging Predictive Value of Tests

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

References (36)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:14:11.755070+00:00
License: CC0 · commercial use OK